✕
Login
Register
Back to News
Catalyst Pharmaceuticals Says District Court Delays Bench Trial To May 18, 2026; Bench Trial Concerns Validity Of FIRDAPSE Patents Expiring In 2032, 2034, 2037
Benzinga Newsdesk
www.benzinga.com
Neutral 92.5%
Neg 0%
Neu 92.5%
Pos 0%
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001369568/000119312526114306/d111324d8k.htm
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment